Get the Stockscreener App
0.7151
6.46%
-0.0494
After Hours:
.72
0.0049
+0.69%
Co Diagnostics Inc stock is traded at $0.7151, with a volume of 273.23K.
It is down -6.46% in the last 24 hours and down -37.27% over the past month.
Co-Diagnostics Inc is a molecular diagnostics company. The company develops, manufactures, licenses, and commercializes reagents used for diagnostic tests that function via the detection and/or analysis of nucleic acid molecules (DNA or RNA), including molecular tools for detection of infectious diseases. CDI's low-cost system uses its tests to diagnose tuberculosis, Zika, hepatitis B and C, Malaria, dengue and others. The Company also uses its proprietary technology to design specific tests for its Co-Dx PCR platform and to locate genetic markers for use in applications other than infectious diseases.
See More
Previous Close:
$0.7645
Open:
$0.79
24h Volume:
273.23K
Relative Volume:
0.55
Market Cap:
$4.99M
Revenue:
$513.90K
Net Income/Loss:
$-48.50M
P/E Ratio:
-0.0255
EPS:
-28.0101
Net Cash Flow:
$-28.99M
1W Performance:
-34.39%
1M Performance:
-37.27%
6M Performance:
-49.64%
1Y Performance:
-93.79%
1-Day Range:
$0.7105
$0.8304
1-Week Range:
$0.7105
$1.30
52-Week Range:
$0.7105
$46.50
Co Diagnostics Inc Stock (CODX) Company Profile
Name
Co Diagnostics Inc
Sector
Industry
Phone
(801) 438-1036
Address
2401 S FOOTHILL DRIVE, SALT LAKE CITY
Compare CODX vs ABT, MDT, SYK, BSX, EW
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
CODX
Co Diagnostics Inc
|
0.7151 | 4.99M | 513.90K | -48.50M | -28.99M | -28.01 |
ABT
Abbott Laboratories
|
104.68 | 181.14B | 46.59B | 5.41B | 7.38B | 3.0938 |
MDT
Medtronic Plc
|
95.45 | 122.09B | 36.36B | 4.84B | 5.43B | 3.7261 |
SYK
Stryker Corp
|
293.23 | 112.48B | 25.27B | 3.34B | 4.57B | 8.6334 |
BSX
Boston Scientific Corp
|
44.14 | 63.97B | 20.62B | 3.56B | 3.48B | 2.3847 |
EW
Edwards Lifesciences Corp
|
88.10 | 50.78B | 6.30B | 1.07B | 1.09B | 1.8406 |
Co Diagnostics Inc Stock (CODX) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Aug-12-22 | Downgrade | Sidoti | Buy → Neutral |
| Dec-29-21 | Initiated | Sidoti | Buy |
| Mar-29-21 | Downgrade | Maxim Group | Buy → Hold |
| May-20-20 | Upgrade | Maxim Group | Hold → Buy |
| May-18-20 | Reiterated | H.C. Wainwright | Buy |
| Mar-09-20 | Reiterated | H.C. Wainwright | Buy |
| Mar-03-20 | Downgrade | Maxim Group | Buy → Hold |
View All
Co Diagnostics Inc Stock (CODX) Latest News
Daniel S Sullivan Stock Trades and Disclosures - TechGraph
Co-Diagnostics (Nasdaq:CODX)Stock Analysis - simplywall.st
Co-Diagnostics, Inc. (CODX) Stock Price, News, Quote & History - Yahoo! Finance Canada
Up to 1-for-50 reverse split on table at Co-Diagnostics (NASDAQ: CODX) - Stock Titan
Ebola outbreak is focus of a New York health roundtable. Co-Dx will join. - Stock Titan
Co-Diagnostics to Hold Press Conference - Yahoo Finance
Co-Diagnostics (CODX) finance EVP details RSU grants vesting through 2028 - Stock Titan
Q1 2026 Co-Diagnostics Inc Earnings Call Transcript - GuruFocus
CeriBell, Inc.Common Stock (CBLL) Stock Price, News, Quote & History - FinancialContent
Co-Diagnostics Completes New Vector Smart® Laboratory Installations Amid Rising Dengue Activity in Florida - PR Newswire
United Natural Foods, ABM Industries and 3 Stocks to Watch Heading Into Tuesday - Benzinga
Weekly Recap: International Vector Smart kit deployment and CFO resignation - TradingView
Co-Diagnostics, Inc. Announces Executive Changes, Effective September 2, 2026 - marketscreener.com
CODX Looks 32.6% Undervalued on GF Value™ Amid Challenging Funda - GuruFocus
Co-Diagnostics Launches Integrated Cloud and Mobile Infrastructure in India - Morningstar
Co-Diagnostics Launches Integrated Cloud and Mobile Infrastructure in India - Yahoo Finance
Co-Diagnostics, Inc. SEC Filing (Sep 2, 2026) - Stock Titan
CODX Looks 31.4% Undervalued on GF Value™ - GuruFocus
A mosquito surveillance system reaches an overseas U.S. Air Force base - Stock Titan
Quest Diagnostics (NYSE: DGX) holder to sell 22,677 shares - Stock Titan
Co-Diagnostics Inc. (CODX) Shareholding Pattern – Promoters, FIIs & DIIs - Value Research
Co-Diagnostics Inc (CODX) Stock News Today - TradingKey
CODX Forecast — Price Target — Prediction for 2027 - tradingview.com
ARMISTICE CAPITAL, LLC Buys Co-Diagnostics Inc (CODX) -- Shares Look 33% Undervalued on GF Value - GuruFocus
Co-Dx (CODX) Q2 2026 Earnings Call Transcript - The Globe and Mail
Co-diagnostics Company Profile & Introduction - Moomoo
Co-Dx (CODX) Q2 2026 Earnings Call Transcript - The Globe and Mail
Co-Diagnostics (CODX) Snapshot: Ends Up by 4.37% at $1.31 in the Current Update; Chart View - vinanet.vn
Co-Diagnostics (CODX) Financial Results: EPS Falls Short of Its Estimate for This Review; Price Reaction: Shares Move 5.97% Lower in the Available RecordEarnings Call Q&A - vinanet.vn
Co-Diagnostics seeks FDA clearance for new PCR Flu A/B & RSV test, prepping for U.S. launch. - Pluang
Co-Diagnostics joins Utah roundtable on AI and medical devices - Stock Titan
Co-Diagnostics Participates in Medical Devices and Innovations Roundtable Media Event - PR Newswire
Maxim Group Upgrades Co-Diagnostics to Buy From Hold, $4 Price Target - marketscreener.com
Company-diagnostics Stock Price Forecast. Should You Buy CODX? - StockInvest.us
Co-Diagnostics Inc (CODX) Stock News Today - TradingKey
Armistice Capital discloses 9.99% Co-Diagnostics (CODX) holding via Master Fund - Stock Titan
Co-diagnostics | SCHEDULE 13G: Others - Moomoo
Co-Diagnostics, Inc. Q2 2026 Earnings Call Summary - Yahoo Finance
Co-diagnostics(CODX) Stock Options Chain | Quotes & News - Moomoo
Co-Diagnostics (CODX) Earnings Call Q2 2026: FDA-Antrag schreitet voran, während Barmittel sinken - TradingKey
Co-Diagnostics (CODX) Q2 2026 Earnings Call: FDA Filing Advances as Cash Falls - TradingKey
Co-Diagnostics Inc (CODX) (Q2 2026) Earnings Call Highlights: FD - GuruFocus
Co-Diagnostics Inc (CODX) (Q2 2026) Earnings Call Highlights: FD - GuruFocus
Is Co-Diagnostics Inc (CODX) Undervalued Despite Q2 Earnings Mis - GuruFocus
Co-Diagnostics Q2 Results: Net loss narrows to $6.3 million - scanx.trade
Co-Diagnostics Reports Q2 2026 Results: Full Earnings Call Transcript - Benzinga
Earnings call transcript: Co-Diagnostics narrows loss in Q2 2026 but revenue stays thin - Investing.com
Co-Diagnostics Inc reports results for the quarter ended June 30Earnings Summary - TradingView
Co-Diagnostics (CODX) Stock Falls on Q2 2026 Earnings - Quiver Quantitative
Q2 2026 Co-Diagnostics Inc Earnings Call Transcript - GuruFocus
Co Diagnostics Inc Stock (CODX) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.00%
0.69%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):